Condronil IALQUATTRO

Description
Sterile, biodegradable, isotonic injectable gel for intra-articular use. Condronil IALQUATTRO consists of a medium molecular weight hyaluronic acid produced by the bacterium Streptococcus equi, formulated at a concentration of 20 mg/ml in a physiological buffer. Condronil IALQUATTRO is characterized by viscoelastic properties, thus promoting the normalization of the viscosity of the synovial fluid present in the intra-articular cavity.
A synovial fluid substitute that, due to its viscoelastic and lubricating properties, promotes the restoration of joint rheology, altered in degenerative or post-traumatic conditions. By improving the characteristics of the synovial fluid, the product protects the joints and promotes improved joint function and pain reduction. Condronil IALQUATTRO acts only at the level of the joint into which it is injected, without exerting any systemic action.

How to use
Remove any joint effusion before injecting Condronil IALQUATTRO; the same needle should be used for removing the effusion and injecting Condronil IALQUATTRO. Remove the protective cap from the syringe, taking special care to avoid contact with the orifice. Screw the 18-22 gauge needle tightly onto the Luer lock collar, following the instructions below. Before injecting, treat the injection site with an appropriate disinfectant.
Inject Condronil IALQUATTRO using aseptic technique. Inject only into the joint cavity.
It is recommended to perform one or more treatment sessions according to medical prescription.
A. Carefully unscrew the cap from the tip of the syringe, taking special care to avoid contact with the orifice.
B. Gently grasp the needle cap and attach the needle to the Luer-lock fitting, screwing firmly until you feel a slight back pressure to ensure a tight seal and prevent gel leakage during administration.

components
Sodium hyaluronate (20 mg/ml), sodium chloride, monosodium phosphate dihydrate, disodium phosphate dodecahydrate, water for injections

warnings
Indicated only for intra-articular injections, such as those in the hip and knee, and should only be dispensed by a physician who has received specific training in intra-articular injection technique.
Before use, check the integrity of the syringe and the expiration date. Do not use needles other than those indicated. The product should be injected into an infected or severely inflamed joint. Infiltration should be avoided in cases of active infection or inflammatory skin conditions near the injection site. Since there are no clinical data available on the use of hyaluronate in children, treatment with Condonil IALQUATTRO in these cases is not recommended. After intra-articular injection, the patient should be advised to avoid physical activities that are demanding on the joint and to resume normal activities after a few days.
Condronil IALQUATTRO is a single-use product; quality and sterility are only guaranteed if the syringe is sealed. Therefore, any residue should be discarded and not reused, even after resterilization.
Do not use the product if the packaging is already open or damaged.
Keep out of reach of children.
The syringe with needle must be discarded immediately after use, even if the solution has not been completely administered. After use, dispose of it according to the regulations in force.

Conservation
Store at 2-25°C, in a dry place, in the original packaging. Protect from light, heat and frost.

Format
Pre-filled syringe containing 4 ml of pyrogen-free gel, sterilized by moist heat.